StockTipsArenaBeta

BUY Krishna Institute of Medical Sciences Limited — IDBI Capital

BUYKrishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))24 Jul 2026via IDBI Capital Research Calls Telegram

Entry₹798Stated
Target₹840
Total upside +5.26% (call closed)
Stop loss₹778-2.51% risk
At expiry₹808.96 Aug 2026, 3:30 pm
Expired+1.37%
Follow IDBI Capital for new calls(25% target hit, 371 closed calls)Get alertsWatch KIMS for new buy/sell callsGet alertsSee 142 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 6 Aug 2026
5 supporting5 neutral1 opposing
Supports the BUY call (5)

Alembic Pharma, KIMS Get Target Price Hikes After Q1, Latent View Sees Downgrade: ICICI Securities

NewsNdtv-Profit·5 Aug · yesterday

(opens in new tab)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·27 Jul · 1w ago

Indian Pharma Q1 FY27 Deals: సన్ ఫార్మా అద్భుతంతో **$13.9 బిలియన్** విలువ నమోదు

NewsGoogle News·23 Jul · 2w ago

(opens in new tab)

सन फार्माच्या डीलमुळे भारतीय फार्मा सेक्टरमध्ये ₹13.9 बिलियनचा व्यवहार; विशेष पोर्टफोलिओवर भर

NewsGoogle News·23 Jul · 2w ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·9 Jul · 4w ago

Neutral / worth noting (5)

Krishna Institute of Medical Sciences Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported total revenue of INR 1,196 Cr, a growth of 36.1% YoY

BSE · Company Update·3 Aug · 2d ago

(opens in new tab)

Krishna Institute of Medical Sciences Limited announced its unaudited financial results for the first quarter ended June 30, 2026. The results will be available on the company's website.

NSE · Press Release·3 Aug · 2d ago

(opens in new tab)

Krishna Institute of Medical Sciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·3 Aug · 2d ago

(opens in new tab)

KIMS Shares Trade Near ₹780 Support Level

NewsGoogle News·27 Jul · 1w ago

(opens in new tab)

KIMS Share Price: ₹780 च्या सपोर्ट लेव्हलवर!

NewsGoogle News·27 Jul · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

KIMS Q1 profit falls 47% despite 35% revenue growth; bed capacity expands

NewsCnbc-Tv18·3 Aug · 2d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Krishna Institute of Medical Sciences

All analyst calls on Krishna Institute of Medical Sciences

More from IDBI Capital

Every call and its outcome